PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(0.0%)
IDR 635.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 438.67 Billion IDR | -3.16% |
| 2022 | 443.65 Billion IDR | -34.58% |
| 2021 | 678.12 Billion IDR | 160.97% |
| 2020 | 259.84 Billion IDR | 17.94% |
| 2019 | 220.31 Billion IDR | 93.43% |
| 2018 | 113.89 Billion IDR | 49.78% |
| 2017 | 76.04 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 127.22 Billion IDR | -16.86% |
| 2024 Q1 | 153.01 Billion IDR | 36.3% |
| 2024 Q3 | 135.91 Billion IDR | 18.16% |
| 2023 Q2 | 115.34 Billion IDR | 55.98% |
| 2023 FY | 429.63 Billion IDR | -3.16% |
| 2023 Q4 | 112.26 Billion IDR | -14.89% |
| 2023 Q3 | 131.9 Billion IDR | 14.36% |
| 2023 Q1 | 73.95 Billion IDR | -13.11% |
| 2022 Q4 | 85.1 Billion IDR | -27.26% |
| 2022 Q3 | 116.99 Billion IDR | 95.67% |
| 2022 Q2 | 59.79 Billion IDR | -67.11% |
| 2022 Q1 | 181.76 Billion IDR | 469.31% |
| 2022 FY | 443.65 Billion IDR | -34.58% |
| 2021 Q2 | 186.42 Billion IDR | 11.78% |
| 2021 Q3 | 292.97 Billion IDR | 57.15% |
| 2021 Q1 | 166.78 Billion IDR | 495.55% |
| 2021 FY | 678.12 Billion IDR | 160.97% |
| 2021 Q4 | 31.92 Billion IDR | -89.1% |
| 2020 Q2 | 122.2 Billion IDR | -39.29% |
| 2020 Q4 | 28 Billion IDR | 125.33% |
| 2020 Q3 | -110.57 Billion IDR | -190.49% |
| 2020 Q1 | 201.27 Billion IDR | 183.81% |
| 2020 FY | 259.84 Billion IDR | 17.94% |
| 2019 Q4 | 70.91 Billion IDR | 0.0% |
| 2019 Q1 | 85.9 Billion IDR | 0.0% |
| 2019 FY | 220.31 Billion IDR | 93.43% |
| 2018 FY | 113.89 Billion IDR | 49.78% |
| 2017 FY | 76.04 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 872.14 Billion IDR | 49.702% |
| PT Itama Ranoraya Tbk | 26.79 Billion IDR | -1537.162% |
| PT Kimia Farma (Persero) Tbk | -1570.24 Billion IDR | 127.936% |
| PT Millennium Pharmacon International Tbk | 105.39 Billion IDR | -316.205% |